PART 201—LABELING
- SUBPART A—General Labeling Provisions (§201.1 to §201.26)
- SUBPART B—Labeling Requirements for Prescription Drugs and/or Insulin (§201.50 to §201.58)
- SUBPART C—Labeling Requirements for Over-the-Counter Drugs (§201.60 to §201.80)
- SUBPART D—Exemptions From Adequate Directions for Use (§201.100 to §201.129)
- SUBPART E—Other Exemptions (§201.150 to §201.161)
- SUBPART F—Labeling Claims for Drugs in Drug Efficacy Study (§201.200 to §201.200)
- SUBPART G—Specific Labeling Requirements for Specific Drug Products (§201.300 to §201.326)